- Illumina sequencing is a widely used next-generation sequencing (NGS) technology that determines the nucleotide sequence of DNA through a process known as sequencing-by-synthesis (SBS). It enables millions to billions of DNA fragments to be sequenced simultaneously, making it possible to analyse entire genomes, exomes, transcriptomes, and targeted genomic regions. Illumina technology has become one of the most important platforms in modern genomics because of its high throughput, reliable base calling, relatively low cost per nucleotide, and extensive support from bioinformatics tools.
- The fundamental principle of Illumina sequencing is the detection of fluorescent signals generated when DNA polymerase incorporates labelled nucleotides into a newly synthesized DNA strand. Each nucleotide type is associated with a distinguishable fluorescent signal and a reversible blocking group. The blocking group temporarily prevents the addition of another nucleotide during the same sequencing cycle. After the incorporated nucleotide is identified through fluorescence detection, the fluorescent label and blocking group are removed, allowing the next nucleotide to be incorporated. Repeating this process determines the sequence of the DNA fragment one base at a time.
- Illumina sequencing is based on massively parallel sequencing. Instead of sequencing one DNA molecule at a time, the technology processes a large number of DNA fragments simultaneously on a solid surface called a flow cell. Each fragment is attached to the flow cell and amplified to form a localized cluster containing many copies of the same original DNA fragment. The instrument detects the fluorescent signals produced by these clusters during successive sequencing cycles and converts them into nucleotide sequences.
- The Illumina sequencing workflow begins with the extraction of DNA or RNA from a biological sample. The starting material may come from human tissue, blood, plants, animals, microorganisms, cultured cells, environmental samples, or other biological sources. DNA quality and concentration are assessed before library preparation. For RNA sequencing, RNA is extracted and converted into complementary DNA (cDNA), which is then used to construct the sequencing library. Sample quality is important because degraded or contaminated nucleic acids can reduce library complexity, introduce biases, and affect sequencing performance.
- Library preparation is the process of converting extracted DNA or cDNA into fragments that can be sequenced by the Illumina platform. Genomic DNA is generally fragmented into smaller pieces using mechanical methods, such as sonication, or enzymatic fragmentation. Some library preparation protocols use transposase enzymes to fragment DNA and attach adapter sequences in a combined process called tagmentation. The appropriate method depends on the sample type, experimental design, desired insert size, and sequencing application.
- After fragmentation, the DNA fragments undergo end repair and adapter addition. End repair prepares the fragment ends for adapter ligation, while A-tailing may add an adenine nucleotide to the 3′ ends to facilitate attachment of adapters containing complementary thymine overhangs. Adapters are short synthetic DNA sequences that contain the elements required for attachment to the sequencing flow cell and for sequencing primer binding. They may also contain index sequences that identify individual samples and enable multiple libraries to be pooled in one sequencing run.
- Index sequences, also called barcodes, are particularly important in multiplexed sequencing. Each sample is assigned a specific index or combination of indices. Multiple indexed libraries can then be combined and sequenced together. During bioinformatics processing, the index sequences are used to assign reads to their original samples through a process known as demultiplexing. Unique molecular identifiers (UMIs) may also be included in some library preparation protocols. Unlike sample indexes, UMIs identify individual original molecules and can help distinguish independent molecules from PCR duplicates.
- Following adapter ligation, the library may undergo PCR amplification to obtain sufficient material for sequencing. PCR amplification is not required in every library preparation protocol; some workflows use amplification-free methods to reduce amplification-associated bias. Library cleanup and size selection remove unwanted fragments, adapter dimers, and other unwanted products. The final library is quantified and assessed for fragment-size distribution before sequencing. Fluorometric assays, quantitative PCR, and instruments such as the Bioanalyzer or TapeStation may be used for library quality assessment.
- The prepared library is loaded onto an Illumina flow cell. A flow cell is a glass or other suitable solid surface containing a large number of immobilized oligonucleotides. These oligonucleotides are complementary to sequences within the library adapters. When the library is introduced into the flow cell, DNA fragments bind to the complementary oligonucleotides through their adapter regions. This attachment provides the foundation for cluster generation.
- Cluster generation is a key step in Illumina sequencing. Once a DNA fragment has attached to the flow cell, its free end bends over and hybridizes to a nearby surface-bound oligonucleotide. DNA polymerase extends the attached strand, producing a double-stranded DNA molecule. The original strand can then be removed or separated, leaving a newly synthesized surface-bound strand. Repeated cycles of bridge amplification generate many copies of the same original fragment within a small, localized area of the flow cell. This group of amplified copies is known as a cluster.
- Clusters provide a sufficiently strong fluorescent signal for optical detection during sequencing. Each cluster originates from a single library fragment, although the cluster contains many amplified copies of that fragment. Ideally, each cluster represents one unique original molecule. However, library amplification, duplicate fragments, and other preparation effects can influence the number and diversity of clusters. The density and quality of clusters affect sequencing performance, so cluster generation must be carefully controlled.
- After cluster generation, the instrument performs sequencing-by-synthesis. DNA polymerase and fluorescently labelled reversible-terminator nucleotides are introduced into the flow cell. During each sequencing cycle, one nucleotide is incorporated into the growing DNA strand at each active cluster. The reversible blocking group prevents further extension during that cycle, ensuring that the signal can be associated with a single incorporated base per strand. The instrument uses optical detection to record the fluorescence emitted by each cluster.
- The four DNA nucleotide types are identified through distinguishable fluorescent signals. The instrument captures images of the flow cell and determines the nucleotide incorporated at each cluster. After signal detection, the fluorescent label and reversible blocking group are chemically removed, restoring the 3′ hydroxyl group required for the next nucleotide incorporation. The process is then repeated. By recording the sequence of fluorescent signals across successive cycles, the instrument reconstructs the nucleotide sequence of each DNA fragment.
- Illumina sequencing systems use different chemistries and instrument configurations, and the precise optical and chemical implementation varies across generations of platforms. The general sequencing-by-synthesis principle remains based on cyclic nucleotide incorporation, signal detection, and removal of the reversible terminator. The number of sequencing cycles determines the nominal read length, subject to the platform and chemistry used.
- Illumina instruments can perform single-end or paired-end sequencing. In single-end sequencing, one end of each DNA fragment is sequenced, producing one read per fragment. In paired-end sequencing, both ends of the same DNA fragment are sequenced, producing two reads, commonly designated Read 1 (R1) and Read 2 (R2). The reads are separated by an unsequenced insert region, and their relative orientation and approximate distance provide additional information about the original DNA fragment.
- For example, a paired-end sequencing configuration of 2 × 150 produces two reads of approximately 150 bases each from opposite ends of a DNA fragment. These reads do not normally form one continuous sequence of 300 bases because the region between them is not necessarily sequenced. Paired-end sequencing is useful for improving read mapping, identifying insertions and deletions, resolving some repetitive regions, detecting certain structural variations, and supporting de novo genome assembly.
- Illumina sequencing also supports multiplexing, allowing multiple samples to be sequenced in a single run. Each library is assigned a unique index or index combination before pooling. After sequencing, the instrument or downstream software uses the index reads to separate the pooled data into sample-specific FASTQ files. Multiplexing improves sequencing efficiency and can reduce the cost per sample. However, the number of samples pooled must be planned according to the expected sequencing output, library quality, and desired sequencing depth for each sample.
- The raw output of Illumina sequencing is processed through instrument software that performs image analysis, signal processing, and base calling. Base calling converts the detected fluorescence signals into nucleotide sequences. The resulting reads are usually stored in FASTQ files, which contain both nucleotide sequences and their corresponding quality scores. Illumina systems commonly produce additional run information and quality metrics that help researchers evaluate sequencing performance.
- A simplified FASTQ record is shown below:
@READ_001
ATGCTAGCTAGCTACGATCG
+
IIIIIIIIIIIIIIIIIIII
- The first line identifies the read, the second contains its nucleotide sequence, the third is a separator, and the fourth contains quality characters encoded using the Phred scale. Actual Illumina read identifiers generally contain additional information, and the quality string depends on the base-calling results. Paired-end sequencing usually produces separate R1 and R2 FASTQ files for each sample.
- Phred quality scores are used to estimate the reliability of individual base calls. They are calculated using the relationship Q = −10 log10(P), where P is the estimated probability of an incorrect base call. A Q20 score corresponds to an estimated error probability of 1%, while Q30 corresponds to an estimated error probability of 0.1%. Higher scores indicate greater estimated base-call confidence. Quality scores are important because sequencing errors can affect read alignment, variant detection, genome assembly, and gene-expression analysis.
- After sequencing, bioinformatics quality control is performed to assess the quality and suitability of the generated reads. FastQC is commonly used to examine per-base sequence quality, GC content, sequence length distribution, adapter contamination, duplication levels, and overrepresented sequences. MultiQC can combine reports from multiple samples into a single summary, making it useful for large sequencing projects. The fastp tool can perform adapter trimming, quality filtering, and other preprocessing operations while generating quality-control reports.
- An example of FastQC analysis for paired-end Illumina reads is:
fastqc sample_R1.fastq.gz sample_R2.fastq.gz \
–outdir fastqc_results
- MultiQC can then summarize the reports:
multiqc fastqc_results \
–outdir multiqc_report
- If adapter contamination or low-quality bases are detected, the reads may be processed using fastp:
fastp \
-i sample_R1.fastq.gz \
-I sample_R2.fastq.gz \
-o sample_R1.trimmed.fastq.gz \
-O sample_R2.trimmed.fastq.gz \
–html fastp_report.html \
–json fastp_report.json
- Quality trimming should be performed carefully because excessive removal of bases can shorten reads, reduce coverage, and discard useful biological information. Some sequencing workflows may also use instrument-generated adapter information or library-specific settings to guide preprocessing.
- After quality control, Illumina reads can be analysed according to the research objective. In reference-based genome analysis, reads are aligned to a reference genome using tools such as BWA-MEM2 or Bowtie2. For RNA sequencing, splice-aware aligners such as STAR and HISAT2 can map reads across exon–exon junctions. The resulting alignments are commonly stored in SAM, BAM, or CRAM formats. SAMtools can be used to convert, sort, index, and inspect alignment files.
- An example of mapping paired-end Illumina DNA reads with BWA-MEM2 is:
bwa-mem2 mem \
reference_genome.fa \
sample_R1.trimmed.fastq.gz \
sample_R2.trimmed.fastq.gz \
> sample.sam
The SAM file can be converted into a sorted and indexed BAM file:
samtools view -bS sample.sam > sample.bam
samtools sort sample.bam -o sample.sorted.bam
samtools index sample.sorted.bam
- The resulting alignment files can be used for coverage analysis, variant calling, and other downstream applications. Reference genome selection is particularly important because differences between genome assemblies can affect read mapping, genomic coordinates, and variant interpretation.
- One of the major applications of Illumina sequencing is whole-genome sequencing (WGS). WGS investigates DNA across the entire genome and can identify single-nucleotide variants, small insertions and deletions, and some larger genomic alterations. It is widely used in human genetics, cancer research, microbial genomics, evolutionary biology, and population genetics. Short-read WGS is particularly effective for identifying many small variants in genomic regions that can be mapped reliably to a suitable reference genome.
- Whole-exome sequencing (WES) is another important application. It focuses on the protein-coding regions of the genome, which are enriched before sequencing through hybridization-based capture or other targeted enrichment methods. WES is frequently used in studies of inherited disorders and rare diseases because many known disease-associated variants occur in protein-coding regions. However, exome capture efficiency varies among regions, and WES does not provide uniform coverage of all coding sequences or comprehensive information about noncoding regions.
- Targeted sequencing uses Illumina technology to investigate selected genes or genomic regions. Targeted panels are commonly used in cancer research, inherited disease studies, pharmacogenomics, and other applications requiring detailed analysis of specific genomic regions. Because sequencing is concentrated on a smaller target, relatively high coverage can be achieved with less sequencing output than whole-genome sequencing. The sensitivity of targeted sequencing depends on assay design, coverage, sample quality, and the variant-calling method.
- Illumina sequencing is also widely used in transcriptomics through RNA sequencing (RNA-seq). In this application, RNA is extracted and converted into cDNA, which is then prepared as a sequencing library. The resulting reads provide information about gene expression, transcript abundance, alternative splicing, and other aspects of RNA biology. Tools such as STAR, HISAT2, Salmon, kallisto, featureCounts, and HTSeq support different stages of RNA-seq analysis. Differential expression analysis can be performed using packages such as DESeq2, edgeR, and limma-voom.
- Another important application is metagenomic sequencing, which analyses DNA from complex microbial communities. Illumina shotgun metagenomics can identify microorganisms and investigate their genetic content without requiring each organism to be cultured separately. Tools such as Kraken2, Bracken, MetaPhlAn, and HUMAnN support taxonomic and functional profiling. Short-read metagenomic data can also be assembled using tools such as MEGAHIT and metaSPAdes. The accuracy of interpretation depends on sequencing depth, community complexity, genome representation, and the quality of reference databases.
- In microbiology and infectious disease research, Illumina sequencing is used for pathogen identification, genome characterization, antimicrobial resistance studies, and outbreak investigation. Whole-genome sequencing can reveal genetic differences among pathogen isolates and support the investigation of possible transmission relationships. However, genomic similarity alone does not establish direct transmission. Epidemiological information, sampling dates, geographical context, and other evidence must also be considered.
- Illumina technology is valuable in agriculture, animal breeding, and plant genomics. It supports genome-wide association studies, genomic selection, genetic diversity analysis, marker discovery, parentage testing, and the identification of variants associated with economically important traits. In crop research, it can be used to investigate genes associated with yield, disease resistance, stress tolerance, and nutritional quality. In livestock research, it can help identify genetic variants related to production, fertility, health, adaptation, and other breeding objectives.
- Illumina sequencing is also used in epigenomics. Bisulfite sequencing can investigate DNA methylation patterns, while chromatin immunoprecipitation sequencing (ChIP-seq) can identify genomic regions associated with particular DNA-binding proteins or histone modifications. Assays such as ATAC-seq use sequencing to investigate chromatin accessibility. These methods generate short reads that are mapped to a reference genome to identify regions of interest. Their interpretation depends on experimental controls, library preparation, sequencing depth, and appropriate statistical analysis.
- Several Illumina sequencing platforms have been developed for different throughput and application requirements. The MiSeq system has commonly been used for smaller projects, targeted sequencing, and applications requiring relatively modest sequencing output. The NextSeq and NovaSeq families have supported higher-throughput sequencing applications, while other instruments and product generations have served different laboratory needs. Platform availability, specifications, read lengths, throughput, and supported chemistries change over time, so researchers should consult current manufacturer documentation when selecting an instrument.
- Despite its many advantages, Illumina sequencing has limitations. Its relatively short reads can make it difficult to resolve long repetitive regions, complex structural variants, segmental duplications, and highly similar genomic regions. Reads that originate from repeated sequences may map to multiple genomic locations, producing ambiguous alignments. This limitation can result in fragmented genome assemblies and incomplete reconstruction of complex genomic regions.
- Illumina sequencing may also be affected by GC-content bias, PCR amplification bias, uneven coverage, contamination, and sequencing errors. Library preparation can introduce biases in the representation of different DNA fragments. PCR duplicates can distort estimates of sequencing depth and allele frequency if they are not appropriately identified or accounted for. In RNA sequencing, transcript abundance estimates can be influenced by transcript length, sequence composition, library preparation, and mapping ambiguity.
- Another limitation is that short reads provide limited direct information about long-range genomic structure and haplotype organization. Paired-end sequencing offers information about the orientation and approximate separation of reads, but it cannot always resolve complex rearrangements or long repetitive regions. Long-read sequencing technologies, including PacBio HiFi and Oxford Nanopore sequencing, can complement Illumina data by providing longer reads that span regions difficult to reconstruct using short-read sequencing alone. Hybrid sequencing strategies combine the strengths of both approaches.
- Sequencing depth must also be planned carefully. Coverage is commonly expressed as the average number of times a reference position is represented by sequencing reads. For example, 30× coverage means that the total number of aligned bases is approximately 30 times the size of the reference genome, averaged across the genome. Actual coverage is not uniform, and some regions may receive substantially more or fewer reads than the average. The required depth depends on the organism, sample type, sequencing application, genome complexity, and sensitivity needed for variant detection.
- For reproducible Illumina sequencing analysis, researchers should document sample preparation, library preparation chemistry, adapter and index design, sequencing instrument, read configuration, sequencing depth, and relevant quality metrics. Raw FASTQ files, instrument reports, quality-control results, reference genome accession and version, software versions, and analysis parameters should be retained. Variant analysis should specify the reference genome build and relevant transcript or gene annotation versions. These details help ensure that results can be independently evaluated and reproduced.
- Illumina sequencing has made large-scale genomic analysis accessible to research laboratories, hospitals, agricultural scientists, and biotechnology organizations. Its sequencing-by-synthesis principle, reversible-terminator chemistry, bridge amplification, fluorescent detection, and extensive bioinformatics ecosystem have made it a central technology in modern molecular research. Although long-read sequencing has expanded the possibilities of genome analysis, Illumina sequencing remains highly important for genome sequencing, transcriptomics, targeted genetic testing, metagenomics, epigenomics, and population studies. Understanding its experimental workflow and computational analysis provides an essential foundation for working with next-generation sequencing data.